These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1930202)

  • 1. Substitution of asparagine for serine-406 of the immunoglobulin mu heavy chain alters glycosylation at asparagine-402.
    Sun WY; Xiong J; Shulman MJ
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1627-34. PubMed ID: 1930202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the mu-chain.
    Wright JF; Shulman MJ; Isenman DE; Painter RH
    J Biol Chem; 1990 Jun; 265(18):10506-13. PubMed ID: 2113058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain.
    Shulman MJ; Pennell N; Collins C; Hozumi N
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7678-82. PubMed ID: 3094013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of asparagine-linked oligosaccharides of five glycosylation sites on immunoglobulin M heavy chain from mineral oil plasmacytoma 104E.
    Anderson DR; Grimes WJ
    J Biol Chem; 1982 Dec; 257(24):14858-64. PubMed ID: 6816800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of peptide deletions on the glycosylation of murine immunoglobulin M heavy chains.
    Finley EM; Rebbe NF; Hickman S
    Arch Biochem Biophys; 1990 Jun; 279(2):395-401. PubMed ID: 2350186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligosaccharide processing at individual glycosylation sites on MOPC 104E immunoglobulin M. Differences in alpha 1,2-linked mannose processing.
    Brown PH; Hickman S
    J Biol Chem; 1986 Feb; 261(6):2575-82. PubMed ID: 3081496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific characterization of the N-linked oligosaccharides of a murine immunoglobulin M by high-performance liquid chromatography/electrospray mass spectrometry.
    Wang F; Nakouzi A; Angeletti RH; Casadevall A
    Anal Biochem; 2003 Mar; 314(2):266-80. PubMed ID: 12654314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for IgM assembly and cytolytic activity. Effects of mutations in the oligosaccharide acceptor site at Asn402.
    Muraoka S; Shulman MJ
    J Immunol; 1989 Jan; 142(2):695-701. PubMed ID: 2911015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role for peptide-oligosaccharide interactions in differential oligosaccharide processing at asparagine-107 of the light chain and asparagine-297 of the heavy chain in a monoclonal IgG1 kappa.
    Savvidou G; Klein M; Grey AA; Dorrington KJ; Carver JP
    Biochemistry; 1984 Jul; 23(16):3736-40. PubMed ID: 6433977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of IgM structures involved in J chain incorporation.
    Wiersma EJ; Chen F; Bazin R; Collins C; Painter RH; Lemieux R; Shulman MJ
    J Immunol; 1997 Feb; 158(4):1719-26. PubMed ID: 9029108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A region of the immunoglobulin-mu heavy chain necessary for forming pentameric IgM.
    Baker MD; Wu GE; Toone WM; Murialdo H; Davis AC; Shulman MJ
    J Immunol; 1986 Sep; 137(5):1724-8. PubMed ID: 3091689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the mouse mu H chain which prevent polymer assembly.
    Davis AC; Collins C; Yoshimura MI; D'Agostaro G; Shulman MJ
    J Immunol; 1989 Aug; 143(4):1352-7. PubMed ID: 2501393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major carbohydrate structures at five glycosylation sites on murine IgM determined by high resolution 1H-NMR spectroscopy.
    Anderson DR; Atkinson PH; Grimes WJ
    Arch Biochem Biophys; 1985 Dec; 243(2):605-18. PubMed ID: 4083905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM polymerization inhibits the Golgi-mediated processing of the mu-chain carboxy-terminal glycans.
    Cals MM; Guenzi S; Carelli S; Simmen T; Sparvoli A; Sitia R
    Mol Immunol; 1996 Jan; 33(1):15-24. PubMed ID: 8604220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sequence at the 3' terminus of mouse immunoglobulin secreted mu chain messenger RNA determined from cloned cDNA.
    Matthyssens G; Rabbitts TH
    Nucleic Acids Res; 1980 Feb; 8(4):703-13. PubMed ID: 6776490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin mu chain.
    Rogers J; Early P; Carter C; Calame K; Bond M; Hood L; Wall R
    Cell; 1980 Jun; 20(2):303-12. PubMed ID: 6771019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of protein and carbohydrate in glycoprotein processing and secretion. Studies using mutants expressing altered IgM mu chains.
    Sidman C; Potash MJ; Köhler G
    J Biol Chem; 1981 Dec; 256(24):13180-7. PubMed ID: 6796582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants.
    Baczynsky WO; Sugii S; Murialdo H; Pennell N; Filkin C; Hozumi N; Shulman MJ
    Nucleic Acids Res; 1983 Nov; 11(21):7471-85. PubMed ID: 6316263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different species of messenger RNA encode receptor and secretory IgM mu chains differing at their carboxy termini.
    Singer PA; Singer HH; Williamson AR
    Nature; 1980 May; 285(5763):294-300. PubMed ID: 6769053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primary structure of the constant part of mu-chain-disease protein BOT.
    Mihaesco E; Barnikol-Watanabe S; Barnikol HU; Mihaesco C; Hilschmann N
    Eur J Biochem; 1980 Oct; 111(1):275-86. PubMed ID: 6777162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.